+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vulvodynia Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Administration Route (Injectable, Oral, Topical), End User - Global Forecast 2025-2030- Product Image
Vulvodynia Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Administration Route (Injectable, Oral, Topical), End User - Global Forecast 2025-2030- Product Image
Sale

Vulvodynia Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Administration Route (Injectable, Oral, Topical), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4807789
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vulvodynia treatment market is evolving rapidly, driven by expanded clinical awareness, multidisciplinary care models, and innovation in both therapeutic delivery and patient monitoring. As industry leaders seek strategic advantage, understanding the current landscape and emerging trends is essential for optimizing patient outcomes and commercial success in this specialized area.

Market Snapshot: Vulvodynia Treatment Market Growth and Trends

The Vulvodynia Treatment Market grew from USD 60.82 billion in 2024 to USD 66.75 billion in 2025. It is expected to continue growing at a CAGR of 9.66%, reaching USD 105.78 billion by 2030. Demand is being driven by increased clinical recognition, patient advocacy, and the integration of innovative treatment modalities across global healthcare systems. The competitive environment continues to evolve as manufacturers, payers, and providers navigate shifting care models and regulatory landscapes.

Scope & Segmentation

  • Treatment Types: Non-pharmacological interventions, such as pelvic floor physical therapy and neuromodulation, alongside pharmacological therapies, including topical anesthetics, anticonvulsants, and antidepressants.
  • Administration Routes: Injectable therapies for targeted muscle intervention, oral agents for systemic symptom management, and topical formulations for localized relief. Innovation in delivery systems is enhancing both compliance and therapeutic duration.
  • End User Settings: Home care with self-administered or caregiver-assisted treatment, hospitals—both private and public—and specialty clinics focused on gynecology or pain management. Each setting presents unique requirements in terms of delivery, support, and patient monitoring.
  • Regional Coverage:
    • Americas: The United States (including major states like California, Texas, and New York), Canada, Mexico, Brazil, and Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies: Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, Endo International plc, Astellas Pharma Inc., Perrigo Company plc, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd.
  • Enabling Technologies: Integration of digital health solutions, wearable monitoring devices, and telehealth platforms to support continuous care and rapid intervention adjustment.

Key Takeaways: Strategic Insights for Senior Leaders

  • Heightened awareness and patient advocacy are propelling vulvodynia into priority status within women’s health, spurring portfolio expansion and service differentiation among stakeholders.
  • Multidisciplinary care—encompassing specialty clinicians, mental health professionals, and physiotherapists—increases treatment effectiveness and fosters comprehensive chronic pain management frameworks.
  • Digital health technologies and personalized medicine approaches are facilitating patient monitoring, adherence, and tailored interventions, reflecting a move toward data-driven decision-making in treatment pathways.
  • Regional heterogeneity in reimbursement systems and regulatory environments shapes both market opportunities and barriers, requiring locally tailored access and engagement strategies.
  • Collaboration among manufacturers, academic centers, and clinical practitioners accelerates translational research and advances the adoption of next-generation therapies.

Tariff Impact: Adjustments in Supply, Pricing, and Partnerships

The introduction of United States tariffs in 2025 has introduced challenges related to cost structure and supply chain configuration in vulvodynia therapeutics. Manufacturers are reassessing sourcing strategies and exploring domestic partnerships to offset increased import duties on active ingredients and specialty delivery systems. This recalibration is also prompting new approaches in pricing negotiations and value-based reimbursement models, with greater emphasis on cost transparency and local regulatory collaboration. Companies are prioritizing onshore production of formulations and delivery mechanisms to improve resilience and secure ongoing product availability.

Methodology & Data Sources

This report applies a multi-source research methodology, triangulating insights from interviews with clinical and healthcare experts, patient perspectives, peer-reviewed literature, clinical trial databases, and corporate filings. Quantitative patterns are validated against anonymized healthcare utilization data, ensuring both reliability and relevance. Iterative peer review guarantees that findings support decision-making with actionable evidence.

Why This Report Matters: Decision-Enabling Insights for Executives

  • Provides comprehensive, segment-level analysis empowering strategic planning and resource allocation across diverse care settings and regional markets.
  • Enables proactive adaptation to regulatory, reimbursement, and tariff-driven changes, aiding in the development of resilient supply and go-to-market strategies.
  • Offers clear benchmarks on competitive landscape and technological innovation to inform partnerships and investment decisions.

Conclusion

The vulvodynia treatment market continues to transition toward integrated, patient-centric care supported by innovation and cross-disciplinary collaboration. Senior decision-makers can apply these insights to build competitive advantage and meet evolving patient and health system needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of neuromodulation devices for refractory vulvodynia pain management
5.2. Growing investment in topical cannabinoid formulations targeting localized vulvar pain relief
5.3. Emergence of microbiome-based therapies focusing on vulvar mucosal health in chronic pain patients
5.4. Integration of telemedicine platforms for remote assessment and management of vulvodynia symptoms
5.5. Rising adoption of multimodal combination therapies integrating hormonal and neuromodulators for vulvodynia
5.6. Accelerated research on neuroinflammatory biomarkers predicting treatment response in vulvodynia patients
5.7. Expansion of patient support programs emphasizing self-care and lifestyle modifications for vulvodynia management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vulvodynia Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non-Pharmacological
8.3. Pharmacological
9. Vulvodynia Treatment Market, by Administration Route
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Vulvodynia Treatment Market, by End User
10.1. Introduction
10.2. Home Care
10.2.1. Caregiver Assisted
10.2.2. Self Administered
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Clinics
10.4.1. Gynecology Clinics
10.4.2. Pain Management Clinics
11. Americas Vulvodynia Treatment Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Vulvodynia Treatment Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Vulvodynia Treatment Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Pfizer Inc.
14.3.2. Viatris Inc.
14.3.3. Teva Pharmaceutical Industries Ltd.
14.3.4. Eli Lilly and Company
14.3.5. Novartis AG
14.3.6. Endo International plc
14.3.7. Astellas Pharma Inc.
14.3.8. Perrigo Company plc
14.3.9. Hikma Pharmaceuticals PLC
14.3.10. Sun Pharmaceutical Industries Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. VULVODYNIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. VULVODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. VULVODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. VULVODYNIA TREATMENT MARKET: RESEARCHAI
FIGURE 22. VULVODYNIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 23. VULVODYNIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 24. VULVODYNIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VULVODYNIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY CAREGIVER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY CAREGIVER ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY GYNECOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY GYNECOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 77. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 78. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 79. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 80. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 81. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 84. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 85. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 88. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 89. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 159. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 164. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 165. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 171. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 190. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 191. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 194. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 195. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 198. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 199. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 207. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 248. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 249. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 255. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 274. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 275. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 278. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 279. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 291. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 319. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 320. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 321. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 327. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 328. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 329. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 330. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 331. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 332. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 333. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 334. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 335. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 338. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 339. TURKEY VULVODYNIA TREATMENT MA

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Novartis AG
  • Endo International plc
  • Astellas Pharma Inc.
  • Perrigo Company plc
  • Hikma Pharmaceuticals PLC
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 66.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 105.78 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Vulvodynia Treatment Market Report 2025 - Product Image

Vulvodynia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Vulvodynia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Vulvodynia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Female Sexual Pain Disorders. Evaluation and Management. Edition No. 2 - Product Image

Female Sexual Pain Disorders. Evaluation and Management. Edition No. 2

  • Book
  • 464 Pages
Diagnostic Gynecologic and Obstetric Pathology. Edition No. 3 - Product Image

Diagnostic Gynecologic and Obstetric Pathology. Edition No. 3

  • Book
Practical Guide to Obstetric and Gynecologic Dermatology - Product Image

Practical Guide to Obstetric and Gynecologic Dermatology

  • Book

About the Vulvodynia Drug Market

Vulvodynia is a chronic pain disorder that affects the vulva, the external female genitalia. It is estimated to affect up to 16% of women in the United States. The Vulvodynia Drug market is a subset of the Sexual and Reproductive Health Drugs market, which includes medications used to treat conditions related to sexual health, such as contraception, infertility, and sexually transmitted infections. Vulvodynia drugs are used to treat the pain associated with the condition, as well as to reduce inflammation and improve overall vulvar health. Common treatments include topical creams, oral medications, and physical therapy. In some cases, surgery may be recommended. The Vulvodynia Drug market is a growing field, with many companies developing new treatments and therapies. Some of the companies in the market include Allergan, Pfizer, Merck, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.